The company has not filed an annual or quarterly report since its Q3 FY2022 10-Q, filed Nov 14, 2022. Its latest SEC filing is a SC 13G/A from Feb 6, 2023.
10-Q for Q3 FY2022, filed Nov 14, 2022
The sections below describe the company as of the FY2021 annual report.
Seeks a business combination with a target company, placing particular emphasis on healthcare opportunities.
10-K for FY2021, filed Mar 31, 2022
No revenue was reported.
10-K for FY2021, filed Mar 31, 2022
8-K, filed Dec 20, 2022
Following such announcement, on December 14, 2022, the New York Stock Exchange (the “NYSE”) notified the Company, and publicly announced…View ↗
8-K, filed Dec 14, 2022
Due to the Company’s inability to consummate an initial business combination by the Amended Termination Date, the Company intends to redeem…View ↗
Loading...